S&P 500   4,221.02
DOW   33,061.57
QQQ   352.01
20 Best Healthcare Dividend Stocks to Invest in
The Graphite Shortage Story You're Not Being Told (Ad)
Nordstrom's Earnings Beat, A Rally In The Making
Money stored in Venmo and other payment apps could be vulnerable, financial watchdog warns
Is Graphite the New Lithium? (Ad)
What is the Penalty for Excess Contributions to an IRA?
Chewy.com Gets A Mouthful Of Profits: Shares Surge, More To Come
Is Graphite the New Lithium? (Ad)
Okta, Inc: When Great Results Aren’t Good Enough 
How to Invest in Specialty Retail Stores
S&P 500   4,221.02
DOW   33,061.57
QQQ   352.01
20 Best Healthcare Dividend Stocks to Invest in
The Graphite Shortage Story You're Not Being Told (Ad)
Nordstrom's Earnings Beat, A Rally In The Making
Money stored in Venmo and other payment apps could be vulnerable, financial watchdog warns
Is Graphite the New Lithium? (Ad)
What is the Penalty for Excess Contributions to an IRA?
Chewy.com Gets A Mouthful Of Profits: Shares Surge, More To Come
Is Graphite the New Lithium? (Ad)
Okta, Inc: When Great Results Aren’t Good Enough 
How to Invest in Specialty Retail Stores
S&P 500   4,221.02
DOW   33,061.57
QQQ   352.01
20 Best Healthcare Dividend Stocks to Invest in
The Graphite Shortage Story You're Not Being Told (Ad)
Nordstrom's Earnings Beat, A Rally In The Making
Money stored in Venmo and other payment apps could be vulnerable, financial watchdog warns
Is Graphite the New Lithium? (Ad)
What is the Penalty for Excess Contributions to an IRA?
Chewy.com Gets A Mouthful Of Profits: Shares Surge, More To Come
Is Graphite the New Lithium? (Ad)
Okta, Inc: When Great Results Aren’t Good Enough 
How to Invest in Specialty Retail Stores
S&P 500   4,221.02
DOW   33,061.57
QQQ   352.01
20 Best Healthcare Dividend Stocks to Invest in
The Graphite Shortage Story You're Not Being Told (Ad)
Nordstrom's Earnings Beat, A Rally In The Making
Money stored in Venmo and other payment apps could be vulnerable, financial watchdog warns
Is Graphite the New Lithium? (Ad)
What is the Penalty for Excess Contributions to an IRA?
Chewy.com Gets A Mouthful Of Profits: Shares Surge, More To Come
Is Graphite the New Lithium? (Ad)
Okta, Inc: When Great Results Aren’t Good Enough 
How to Invest in Specialty Retail Stores

Aurora Cannabis (ACB) Price Target & Analyst Ratings

$0.50
-0.01 (-1.95%)
(As of 06/1/2023 ET)
Compare
Today's Range
$0.49
$0.56
50-Day Range
$0.50
$0.71
52-Week Range
$0.49
$1.94
Volume
4.43 million shs
Average Volume
4.97 million shs
Market Capitalization
$177.08 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$1.40

Aurora Cannabis Consensus Rating and Price Target (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Hold
Based on 6 Analyst Ratings

Consensus Analyst Price Target

$1.58
212.75% Upside
High Prediction$2.15
Average Prediction$1.58
Low Prediction$1.00
TypeCurrent
6/2/22 to 6/2/23
1 Month Ago
5/3/22 to 5/3/23
3 Months Ago
3/4/22 to 3/4/23
1 Year Ago
6/2/21 to 6/2/22
Consensus Rating
Hold
Hold
Hold
Hold
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
1 Buy rating(s)
1 Buy rating(s)
1 Buy rating(s)
0 Buy rating(s)
Hold
5 Hold rating(s)
5 Hold rating(s)
5 Hold rating(s)
5 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
2 Sell rating(s)
Consensus Price Target$1.58$1.58$1.58$6.93
Predicted Upside212.75% Upside15.35% Upside15.35% Upside2.87% Upside
Get Aurora Cannabis Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for ACB and its competitors with MarketBeat's FREE daily newsletter.


ACB Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

ACB Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Aurora Cannabis Stock vs. The Competition

TypeAurora CannabisMedical CompaniesS&P 500
Consensus Rating Score
2.17
2.66
2.48
Consensus RatingHoldBuyHold
Predicted Upside212.75% Upside1,273.90% Upside203.34% Upside
News Sentiment RatingVery Positive News
Neutral News
Positive News

Historical Target Prices and Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
2/13/2023CIBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetC$2.25 ➝ C$1.75
1/27/2023Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetC$1.75 ➝ C$1.45
12/28/2022Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$2.00 ➝ $1.00+16.08%
9/22/2022Atb Cap Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
F. Gomes
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeUnderperform ➝ Sector Perform
9/21/2022Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeSell ➝ Hold
6/24/2022Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeNeutral ➝ Overweight
(Data available from 6/2/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)












ACB Price Target - Frequently Asked Questions

What is Aurora Cannabis's consensus rating and price target?

According to the issued ratings of 6 analysts in the last year, the consensus rating for Aurora Cannabis stock is Hold based on the current 5 hold ratings and 1 buy rating for ACB. The average twelve-month price prediction for Aurora Cannabis is $1.58 with a high price target of $2.15 and a low price target of $1.00. Learn more on ACB's analyst rating history.

Do Wall Street analysts like Aurora Cannabis more than its competitors?

Analysts like Aurora Cannabis less than other Medical companies. The consensus rating for Aurora Cannabis is Hold while the average consensus rating for medical companies is Buy. Learn more on how ACB compares to other companies.

Does Aurora Cannabis's stock price have much upside?

According to analysts, Aurora Cannabis's stock has a predicted upside of 15.35% based on their 12-month price targets.


Stock Ratings Reports and Tools

This page (NYSE:ACB) was last updated on 6/2/2023 by MarketBeat.com Staff

My Account -